Nephros Inc (NEPH)
2.16
-0.03
(-1.37%)
USD |
NASDAQ |
Apr 26, 16:00
2.16
0.00 (0.00%)
After-Hours: 20:00
Nephros Price to Book Value: 2.725 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 2.763 |
| April 24, 2024 | 2.763 |
| April 23, 2024 | 2.700 |
| April 22, 2024 | 2.637 |
| April 19, 2024 | 2.649 |
| April 18, 2024 | 2.561 |
| April 17, 2024 | 2.510 |
| April 16, 2024 | 2.561 |
| April 15, 2024 | 2.523 |
| April 12, 2024 | 2.523 |
| April 11, 2024 | 2.524 |
| April 10, 2024 | 2.674 |
| April 09, 2024 | 2.763 |
| April 08, 2024 | 2.712 |
| April 05, 2024 | 2.750 |
| April 04, 2024 | 2.738 |
| April 03, 2024 | 2.775 |
| April 02, 2024 | 2.775 |
| April 01, 2024 | 2.775 |
| March 28, 2024 | 2.763 |
| March 27, 2024 | 2.864 |
| March 26, 2024 | 2.788 |
| March 25, 2024 | 2.750 |
| March 22, 2024 | 2.990 |
| March 21, 2024 | 2.788 |
| Date | Value |
|---|---|
| March 20, 2024 | 2.788 |
| March 19, 2024 | 2.725 |
| March 18, 2024 | 2.662 |
| March 15, 2024 | 2.738 |
| March 14, 2024 | 2.725 |
| March 13, 2024 | 2.851 |
| March 12, 2024 | 2.927 |
| March 11, 2024 | 3.078 |
| March 08, 2024 | 3.406 |
| March 07, 2024 | 3.810 |
| March 06, 2024 | 3.911 |
| March 05, 2024 | 3.797 |
| March 04, 2024 | 3.747 |
| March 01, 2024 | 3.898 |
| February 29, 2024 | 3.986 |
| February 28, 2024 | 3.911 |
| February 27, 2024 | 4.226 |
| February 26, 2024 | 4.358 |
| February 23, 2024 | 4.693 |
| February 22, 2024 | 4.466 |
| February 21, 2024 | 4.415 |
| February 20, 2024 | 4.422 |
| February 16, 2024 | 4.431 |
| February 15, 2024 | 4.428 |
| February 14, 2024 | 4.415 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.066
Minimum
Sep 29 2022
23.80
Maximum
Oct 17 2019
6.504
Average
5.971
Median
Apr 30 2021
Price to Book Value Benchmarks
| Perspective Therapeutics Inc | 12.41 |
| Retractable Technologies Inc | 0.3234 |
| Xtant Medical Holdings Inc | 2.384 |
| Asensus Surgical Inc | 2.024 |
| Catheter Precision Inc | 0.1967 |
Price to Book Value Related Metrics
| PS Ratio | 1.576 |
| Price to Free Cash Flow | 27.13 |
| Price | 2.16 |
| Earnings Yield | -6.94% |
| Market Cap | 22.77M |